e-learning
resources
Amsterdam 2015
Monday, 28.09.2015
Cystic fibrosis: physiology, biomarkers, microbiology and miscellaneous
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
CF-ABLE-UK score: Modification and validation of a clinical prediction rule for prognosis in cystic fibrosis on data from UK CF registry
Borislav Dimitrov (Southampton, United Kingdom), Borislav D. Dimitrov, Mohd Hafiz Hj Jaidi
Source:
International Congress 2015 – Cystic fibrosis: physiology, biomarkers, microbiology and miscellaneous
Session:
Cystic fibrosis: physiology, biomarkers, microbiology and miscellaneous
Session type:
Poster Discussion
Number:
2064
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Borislav Dimitrov (Southampton, United Kingdom), Borislav D. Dimitrov, Mohd Hafiz Hj Jaidi. CF-ABLE-UK score: Modification and validation of a clinical prediction rule for prognosis in cystic fibrosis on data from UK CF registry. Eur Respir J 2015; 46: Suppl. 59, 2064
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: What’s NEW in the 2022 ERS/ATS PFT Interpretation Statement
From pulmonary gas exchange to the interpretation of arterial blood gases
The physiology of breathlessness
Related content which might interest you:
Does the lung clearance index track with disease progression in early childhood?
Source: International Congress 2015 – Cystic fibrosis: physiology, biomarkers, microbiology and miscellaneous
Year: 2015
Ability of lung clearance index to track changes in a routine clinical CF setting
Source: International Congress 2015 – Paediatric respiratory physiology
Year: 2015
Use of national disease registries in the conduct of long-term post-authorisation drug safety studies (LTSSs)
Source: International Congress 2016 – Cystic fibrosis: inflammation, microbiology, management and monitoring
Year: 2016
Factors associated with poor pulmonary function: cross-sectional analysis of data from the ERCF
Source: Eur Respir J 2001; 18: 298-305
Year: 2001
Impact of frailty on interpretability of spirometry: The Rotterdam study
Source: Annual Congress 2013 –Assessing the prevalence of COPD in the general population
Year: 2013
Lung clearance Index changes over time among patients with cystic fibrosis
Source: International Congress 2015 – New findings in paediatric respiratory physiology
Year: 2015
Predicting mortality in idiopathic pulmonary fibrosis. Which parameters should be used to determine eligibility for treatment? Analysis of a UK prospective cohort
Source: International Congress 2016 – The best is yet to come in terms of lung function
Year: 2016
Longitudinal assessment of Lung Clearance Index as a marker of disease progression in a cohort of children with cystic fibrosis and normal spirometry
Source: Virtual Congress 2020 – New frontiers in cystic fibrosis imaging and lung physiology
Year: 2020
Relationship of baseline or annual change of clinical parameters on mortality in patients with COPD
Source: Annual Congress 2013 –Risk factors for COPD and lung function decline
Year: 2013
Correlation of nutritional status using subjective global assessment (SGA) on pulmonary function parameters in patients with COPD at the Philippine Heart Center
Source: Annual Congress 2013 –Disease control and quality of life in airway diseases
Year: 2013
Respiratory function and the risk of lung cancer in COPD patients: A population-based cohort study
Source: International Congress 2016 – Epidemiology and specific subgroups in lung cancer
Year: 2016
Assessment of NuvoAir platform use on clinical outcomes in adults with cystic fibrosis: a first Italian experience
Source: Virtual Congress 2021 – Cystic fibrosis
Year: 2021
Health status predicts long-term outcomes in patients with chronic obstructive pulmonary disease (COPD): Pooled analysis of patient-level data from the COPD biomarker qualification consortium database
Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Year: 2015
Disease characteristics and outcomes in a Swedish cohort of patients with pulmonary fibrosis (PF)
Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs)
Year: 2018
Distribution and significance of GOLD 2011 disease severity classification in patients with COPD in China: A national cross-sectional survey
Source: Annual Congress 2013 –COPD: acute exacerbations and others
Year: 2013
Mortality risk prediction in COPD by a prognostic biomarker panel – Results of a derivation and validation cohort with a long term follow-up
Source: International Congress 2014 – Markers
Year: 2014
Validation of a Japanese version of the COPD diagnostic questionnaire in the general Asian population: The Hisayama study
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013
PROOF-registry: A prospective observational registry to describe the disease course and outcomes of idiopathic pulmonary fibrosis patients in a real-world clinical setting
Source: International Congress 2014 – ILDs 6
Year: 2014
Assessment of the work of breathing (sWOB) within different functional and genetic groups in patients with cystic fibrosis (CF)
Source: Annual Congress 2013 –New perspectives of lung function assessment in children
Year: 2013
CPOD and lung function parameters as predictors of mortality: Results from the Latin American PLATINO cohort study
Source: International Congress 2014 – Longitudinal studies of respiratory disease
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept